Resonance Raman studies of cytochrome P450BM3 and its complexes with exogenous ligands.
Resonance Raman spectra are reported for both the heme domain and holoenzyme of cytochrome P450BM3 in the resting state and for the ferric NO, ferrous CO, and ferrous NO adducts in the absence and presence of the substrate, palmitate. Comparison of the spectrum of the palmitate-bound form of the heme domain with that of the holoenzyme indicates that the presence of the flavin reductase domain alters the structure of the heme domain in such a way that water accessibility to the distal pocket is greater for the holoenzyme, a result that is consistent with analogous studies of cytochrome P450cam. The data for the exogenous ligand adducts are compared to those previously reported for corresponding derivatives of cytochrome P450cam and document significant and important differences for the two proteins. Specifically, while the binding of substrate induces relatively dramatic changes in the nu(Fe-XY) modes of the ferrous CO, ferric NO, and ferrous NO derivatives of cytochrome P450cam, no significant changes are observed for the corresponding derivatives of cytochrome P450BM3 upon binding of palmitate. In fact, the spectral data for substrate-free cytochrome P450BM3 provide evidence for distortion of the Fe-XY fragment, even in the absence of substrate. This apparent distortion, which is nonexistent in the case of substrate-free cytochrome P450cam, is most reasonably attributed to interaction of the Fe-XY fragment with the F87 phenylalanine side chain. This residue is known to lie very close to the heme iron in the substrate-free derivative of cytochrome P450BM3 and has been suggested to prevent hydroxylation of the terminal, omega, position of long-chain fatty acids.
Deng
T J
TJ
Beckman Institute for Advanced Science and Technology, Department of Biochemistry, University of Illinois, Urbana 61081, USA.
Proniewicz
L M
LM
Kincaid
J R
JR
Yeom
H
H
Macdonald
I D
ID
Sligar
S G
SG
D001410:Bacillus megaterium / Q000201:enzymology; D001426:Bacterial Proteins; D019475:Camphor 5-Monooxygenase / Q000737:chemistry; D002248:Carbon Monoxide / Q000737:chemistry; D003577:Cytochrome P-450 Enzyme System / Q000737:chemistry*; D005290:Ferric Compounds / Q000737:chemistry; D005296:Ferrous Compounds / Q000737:chemistry; D006418:Heme / Q000737:chemistry; D020035:Holoenzymes / Q000737:chemistry; D008024:Ligands; D046911:Macromolecular Substances; D006899:Mixed Function Oxygenases / Q000737:chemistry*; D009251:NADPH-Ferrihemoprotein Reductase; D009569:Nitric Oxide / Q000737:chemistry; D017434:Protein Structure, Tertiary; D013059:Spectrum Analysis, Raman; D013379:Substrate Specificity
D001426:Bacterial Proteins; D005290:Ferric Compounds; D005296:Ferrous Compounds; D020035:Holoenzymes; D008024:Ligands; D046911:Macromolecular Substances; D009569:Nitric Oxide; D006418:Heme; D002248:Carbon Monoxide; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D019475:Camphor 5-Monooxygenase; D009251:NADPH-Ferrihemoprotein Reductase; C052423:flavocytochrome P450 BM3 monoxygenases